FDA Inspection 854295 — Northern Indiana Cancer Research Consortium IRB
The FDA completed an inspection of Northern Indiana Cancer Research Consortium IRB on November 5, 2013 in South Bend, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 5, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- South Bend, IN (United States)
Additional Details
IRB